The Signs Of Autism Spectrum Disorders.
The 10 to 20 minutes of a representative well-child by isn't enough adjust to reliably detect a young child's gamble of autism, a new study suggests. "When decisions about autism referral are made based on thumbnail observations alone, there is a landed risk that even experts may miss a large interest of children who need a referral for further evaluation," said lead swatting author Terisa Gabrielsen. She conducted the study while at the University of Utah but is now an auxiliary professor in the department of counseling, emotion and special education at Brigham Young University in Provo, Utah more info. "In this study, the children with autism spectrum unrest were missed because they exhibited standard behavior much of the time during short video segments," explained one expert, Dr Andrew Adesman, leading of developmental and behavioral pediatrics at Cohen Children's Medical Center of New York.
And "Video clips without clinical frame are not enough to constitute a diagnosis - just like the presence of a fever and cough doesn't sordid a child has pneumonia". In the study, Gabrielsen's band videotaped two 10-minute segments of children, venerable 15 months to 33 months, while they underwent three assessments for autism, including the "gold standard" examine known as the Autism Diagnostic Observation Schedule. The 42 children included 14 already diagnosed with untimely signs of an autism spectrum disorder, 14 without autism but with suspected speech delays and 14 who were typically developing.
The researchers then showed the videos to two psychologists who specialized in autism spectrum disorders. These experts rated characteristic and atypical behaviors observed, and stubborn whether they would send that newborn for an autism evaluation. About 11 percent of the autistic children's video clips showed atypical behavior, compared to 2 percent of the typically developing children's video clips. But that meant 89 percent of the behavior seen amongst the children with autism was popular as typical, the ponder authors noted.
And "With only a few atypical behaviors, and many more conventional behaviors observed, we shady that the sway of regular behavior in a short stopover may be influencing referral decisions, even when atypical behavior is present". When the autism experts picked out who they idea should be referred for an autism assessment, they missed 39 percent of the children with autism, the researchers found. "We were surprised to discovery that even children with autism were showing predominantly normal behavior during terse observations.
A brief proclamation doesn't allow for multiple occurrences of infrequent atypical behavior to become express amidst all the typical behavior". The findings, published online Jan 12, 2015 in the quarterly Pediatrics, were less surprising to pediatric neuropsychologist Leandra Berry, accomplice administrator of clinical services for the Autism Center at Texas Children's Hospital. "This is an intriguing study that provides an important prompt of how difficult it can be to identify autism, particularly in very young children.
While informative, these findings are not strikingly surprising, particularly to autism specialists who have in-depth instruction of autism symptoms and how symptoms may be present or absent, or more inexorable or milder, in different children and at different ages". The observations in this contemplation also differ from what a clinician might pick up during an in-person visit. "It is noteworthy that information be gained from the child's parents and other caregivers.
Showing posts with label months. Show all posts
Showing posts with label months. Show all posts
Tuesday, May 7, 2019
Friday, December 28, 2018
The Experimental Drug Against Lung Cancer Prolongs Patients' Lives
The Experimental Drug Against Lung Cancer Prolongs Patients' Lives.
Researchers gunshot they prolonged survival for some patients with advanced non-small cubicle lung cancer, for whom the median survival is currently only about six months. One learn discovered that an exploratory benumb called crizotinib shrank tumors in the the better of lung cancer patients with a specific gene variant click for source. An estimated 5 percent of lung cancer patients, or ruthlessly 40000 community worldwide, have this gene variant.
A supporter study found that a double-chemotherapy regimen benefited advanced in years patients, who represent the majority of those with lung cancer worldwide. Roughly 100000 patients with lung cancer in the United States are over the time of 70. "This is our toughest cancer in many ways," said Dr Mark Kris, president of a Saturday multitude discussion at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. "It affects 220000 Americans each year, and over a million man worldwide. Sadly, it is our nation's - and our world's - outstanding cancer".
The beginning study, a phase 1 trial, found that 87 percent of 82 patients with advanced non-small room lung cancer with a established mutation of the ALK gene, which makes that gene mix with another, responded robustly to curing with crizotinib, which is made by Pfizer Inc. "The patients were treated for an common of six months, and more than 90 percent adage their tumors shrink in size and 72 percent of participants remained progression-free six months after treatment," said chew over founder Dr Yung-Jue Bang, a professor in the subdivision of internal medicine at Seoul National University College of Medicine in South Korea. Ordinarily, only about 10 percent of patients would be expected to retort to treatment.
About half of patients trained nausea, vomiting and diarrhea but these party effects eased over time. The fusion gene was victory discovered to play a capacity in this type of lung cancer in 2007. Researchers are now working on a look 3 trial of the drug. The Korean researchers reported economic ties to Pfizer.
Researchers gunshot they prolonged survival for some patients with advanced non-small cubicle lung cancer, for whom the median survival is currently only about six months. One learn discovered that an exploratory benumb called crizotinib shrank tumors in the the better of lung cancer patients with a specific gene variant click for source. An estimated 5 percent of lung cancer patients, or ruthlessly 40000 community worldwide, have this gene variant.
A supporter study found that a double-chemotherapy regimen benefited advanced in years patients, who represent the majority of those with lung cancer worldwide. Roughly 100000 patients with lung cancer in the United States are over the time of 70. "This is our toughest cancer in many ways," said Dr Mark Kris, president of a Saturday multitude discussion at the annual meeting of the American Society of Clinical Oncology (ASCO), in Chicago. "It affects 220000 Americans each year, and over a million man worldwide. Sadly, it is our nation's - and our world's - outstanding cancer".
The beginning study, a phase 1 trial, found that 87 percent of 82 patients with advanced non-small room lung cancer with a established mutation of the ALK gene, which makes that gene mix with another, responded robustly to curing with crizotinib, which is made by Pfizer Inc. "The patients were treated for an common of six months, and more than 90 percent adage their tumors shrink in size and 72 percent of participants remained progression-free six months after treatment," said chew over founder Dr Yung-Jue Bang, a professor in the subdivision of internal medicine at Seoul National University College of Medicine in South Korea. Ordinarily, only about 10 percent of patients would be expected to retort to treatment.
About half of patients trained nausea, vomiting and diarrhea but these party effects eased over time. The fusion gene was victory discovered to play a capacity in this type of lung cancer in 2007. Researchers are now working on a look 3 trial of the drug. The Korean researchers reported economic ties to Pfizer.
Thursday, July 19, 2018
Within 6 Months After The Death Of A Loved One Or Child Has An Increased Risk Of Heart Attack
Within 6 Months After The Death Of A Loved One Or Child Has An Increased Risk Of Heart Attack.
In the months following the dying of a spouse or a child, the surviving spouse or begetter may facing a higher hazard of marrow attack or hasty cardiac death due to an increased heart rate, original research suggests. The risk tends to dissipate within six months, the deliberate over authors said scriptovore com. "While the focus at the patch of bereavement is naturally directed toward the deceased person, the robustness and welfare of bereaved survivors should also be of concern to medical professionals, as well as class and friends," study lead author Thomas Buckley, acting vice-president of postgraduate studies at the University of Sydney Nursing School in Sydney, Australia, said in an American Heart Association word release.
And "Some bereaved especially those already at increased cardiovascular risk, might gain from medical review, and they should try medical benefit for any possible cardiac symptoms". Buckley and his colleagues are scheduled to adduce their observations Sunday at the annual meeting of the American Heart Association, in Chicago. While former research has indicated that understanding health may be compromised among the bereaved, it has remained unclear what in every respect drives this increased risk and why the risk diminishes over time.
The revitalized study suggests that there is a psychological dimension to the dynamic, one centered around a fugitive increase in the incidence of stress and depression. The analyse authors examined the issue by tracking 78 bereaved spouses and parents between the ages of 33 and 91 (55 women and 23 men) for six months, starting within the two-week days following the disappointment of their toddler or spouse.
In the months following the dying of a spouse or a child, the surviving spouse or begetter may facing a higher hazard of marrow attack or hasty cardiac death due to an increased heart rate, original research suggests. The risk tends to dissipate within six months, the deliberate over authors said scriptovore com. "While the focus at the patch of bereavement is naturally directed toward the deceased person, the robustness and welfare of bereaved survivors should also be of concern to medical professionals, as well as class and friends," study lead author Thomas Buckley, acting vice-president of postgraduate studies at the University of Sydney Nursing School in Sydney, Australia, said in an American Heart Association word release.
And "Some bereaved especially those already at increased cardiovascular risk, might gain from medical review, and they should try medical benefit for any possible cardiac symptoms". Buckley and his colleagues are scheduled to adduce their observations Sunday at the annual meeting of the American Heart Association, in Chicago. While former research has indicated that understanding health may be compromised among the bereaved, it has remained unclear what in every respect drives this increased risk and why the risk diminishes over time.
The revitalized study suggests that there is a psychological dimension to the dynamic, one centered around a fugitive increase in the incidence of stress and depression. The analyse authors examined the issue by tracking 78 bereaved spouses and parents between the ages of 33 and 91 (55 women and 23 men) for six months, starting within the two-week days following the disappointment of their toddler or spouse.
Friday, April 21, 2017
Pain Is A Harbinger Of The Last Months Of Life At Half The Elderly
Pain Is A Harbinger Of The Last Months Of Life At Half The Elderly.
Pain is a commonly reported characteristic during the hold out few years of life, with reports of torment increasing during the unalterable few months, a imaginative study has shown. Just over a fourth of people reported being "troubled" by cool or severe pain two years before they died, the researchers found. At four months before death, that many had jumped to nearly half cheap hgh factor. "This consider shows that there's a profitable burden of pain at the end of life, and not just the very end of life," said the study's tether author, Dr Alexander K Smith, an second professor of medicine at the University of California, San Francisco, and a alpenstock physician at the San Francisco VA Medical Center.
And "Arthritis was the one biggest predictor of pain". Results of the deliberate over are published in the Nov 2, 2010 issue of the Annals of Internal Medicine. Smith and his co-authors spiculate out that numerous studies have been done on sadden associated with specific conditions, such as cancer, but that theirs may be the firstly to address pain from all conditions toward the end of life, a time when most kin would say that being pain-free is a priority.
The study included dope on more than 4700 people who died while participating in a study of older adults called the Health and Retirement Study. The enquiry participants averaged 76 years old, included slight more men than women and were mostly (83 percent) white. Every two years, they were asked if they were troubled by pain. If they answered yes, they were asked to clip their bother as mild, blunt or severe.
Pain is a commonly reported characteristic during the hold out few years of life, with reports of torment increasing during the unalterable few months, a imaginative study has shown. Just over a fourth of people reported being "troubled" by cool or severe pain two years before they died, the researchers found. At four months before death, that many had jumped to nearly half cheap hgh factor. "This consider shows that there's a profitable burden of pain at the end of life, and not just the very end of life," said the study's tether author, Dr Alexander K Smith, an second professor of medicine at the University of California, San Francisco, and a alpenstock physician at the San Francisco VA Medical Center.
And "Arthritis was the one biggest predictor of pain". Results of the deliberate over are published in the Nov 2, 2010 issue of the Annals of Internal Medicine. Smith and his co-authors spiculate out that numerous studies have been done on sadden associated with specific conditions, such as cancer, but that theirs may be the firstly to address pain from all conditions toward the end of life, a time when most kin would say that being pain-free is a priority.
The study included dope on more than 4700 people who died while participating in a study of older adults called the Health and Retirement Study. The enquiry participants averaged 76 years old, included slight more men than women and were mostly (83 percent) white. Every two years, they were asked if they were troubled by pain. If they answered yes, they were asked to clip their bother as mild, blunt or severe.
Thursday, March 16, 2017
Extension Of Receiving Antiviral Drugs Reduces The Risk Of Lung Rejection After Transplantation
Extension Of Receiving Antiviral Drugs Reduces The Risk Of Lung Rejection After Transplantation.
Extended antiviral remedying after a lung move may aide nip in the bud dangerous complications and organ rejection, a new investigate from Duke University Medical Center shows. A proverbial cause of infection in lung transplant recipients is cytomegalovirus (CMV), which often causes tractable effects but can be life-threatening for transplant patients. Standard obstacle therapy involves taking the drug valganciclovir (Valcyte) for up to three months lipitor t218. But even with this treatment, most lung uproot patients blossom CMV infections within a year.
The Duke study included 136 patients who completed three months of enunciated valganciclovir and then received either an additional nine months of placebo (66 patients) or an additional nine months of articulated valganciclovir (70 patients). Since it was a double-blind, placebo-controlled randomized study, researchers compared two groups of randomly selected patients at 11 unlike centers (one categorize of which received the additional medication and a hold sway over coterie that received the placebo, with neither the researchers nor the participants knowledgable who was in the charge group). Researchers found that CMV infection occurred in 10 percent of the extended care group, compared to 64 percent of the placebo group.
Extended antiviral remedying after a lung move may aide nip in the bud dangerous complications and organ rejection, a new investigate from Duke University Medical Center shows. A proverbial cause of infection in lung transplant recipients is cytomegalovirus (CMV), which often causes tractable effects but can be life-threatening for transplant patients. Standard obstacle therapy involves taking the drug valganciclovir (Valcyte) for up to three months lipitor t218. But even with this treatment, most lung uproot patients blossom CMV infections within a year.
The Duke study included 136 patients who completed three months of enunciated valganciclovir and then received either an additional nine months of placebo (66 patients) or an additional nine months of articulated valganciclovir (70 patients). Since it was a double-blind, placebo-controlled randomized study, researchers compared two groups of randomly selected patients at 11 unlike centers (one categorize of which received the additional medication and a hold sway over coterie that received the placebo, with neither the researchers nor the participants knowledgable who was in the charge group). Researchers found that CMV infection occurred in 10 percent of the extended care group, compared to 64 percent of the placebo group.
Tuesday, March 14, 2017
A New Therapeutic Vaccine Against Prostate Cancer
A New Therapeutic Vaccine Against Prostate Cancer.
A newly approved salutary prostate cancer vaccine won the back Wednesday of a Medicare hortatory committee, increasing the chances that Medicare will income for the drug. Officials from Medicare, the federal cover program for the elderly and disabled, will meditate the committee's vote when making a final decision on payment. Such a resolving is expected in several months, the Wall Street Journal reported contact penis enlargement in ghana. The vaccine, called Provenge and made by the Dendreon Corp, costs $93000 per sufferer and extends survival by about four months on average, according to results from clinical trials.
A go into published in July in the New England Journal of Medicine found that the vaccine extended the lives of men with metastatic tumors intractable to ideal hormonal treatment, compared with no treatment. And the psychotherapy active less toxicity than chemotherapy.
Provenge is a healthy (not preventive) vaccine made from the patient's own snow-white blood cells. Once removed from the patient, the cells are treated with the antidepressant and placed back into the patient. These treated cells then trigger an unaffected reply that in turn kills cancer cells, leaving usual cells unharmed.
The vaccine is given intravenously in a three-dose assign delivered in two-week intervals. "The strategy of trying to harness the unsusceptible system to fight cancer has been something that subjects have tried to attain for many years; this is one such strategy," study lead researcher Dr Philip Kantoff, a professor of drug at Harvard Medical School and a medical oncologist at the Dana-Farber Cancer Institute in Boston, told HealthDay.
A newly approved salutary prostate cancer vaccine won the back Wednesday of a Medicare hortatory committee, increasing the chances that Medicare will income for the drug. Officials from Medicare, the federal cover program for the elderly and disabled, will meditate the committee's vote when making a final decision on payment. Such a resolving is expected in several months, the Wall Street Journal reported contact penis enlargement in ghana. The vaccine, called Provenge and made by the Dendreon Corp, costs $93000 per sufferer and extends survival by about four months on average, according to results from clinical trials.
A go into published in July in the New England Journal of Medicine found that the vaccine extended the lives of men with metastatic tumors intractable to ideal hormonal treatment, compared with no treatment. And the psychotherapy active less toxicity than chemotherapy.
Provenge is a healthy (not preventive) vaccine made from the patient's own snow-white blood cells. Once removed from the patient, the cells are treated with the antidepressant and placed back into the patient. These treated cells then trigger an unaffected reply that in turn kills cancer cells, leaving usual cells unharmed.
The vaccine is given intravenously in a three-dose assign delivered in two-week intervals. "The strategy of trying to harness the unsusceptible system to fight cancer has been something that subjects have tried to attain for many years; this is one such strategy," study lead researcher Dr Philip Kantoff, a professor of drug at Harvard Medical School and a medical oncologist at the Dana-Farber Cancer Institute in Boston, told HealthDay.
Monday, January 23, 2017
New Researches In Treatment Of Rheumatoid Arthritis
New Researches In Treatment Of Rheumatoid Arthritis.
About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a unknown examination finds June 2013. Rheumatoid arthritis affects about one in 100 citizenry worldwide and can cause advancing collaborative destruction, deformity, woe and stiffness. The disease can reduce corporeal function, quality of life and life expectancy. The pipe reason about one-third of patients discontinued their medications was because the drugs astray their effectiveness, the study authors found glucophage treatment. Other reasons included shelter concerns (20 percent), doctor favourite (nearly 28 percent), patient preference (about 18 percent) and access to therapy (9 percent), according to the sanctum results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.
Rheumatoid arthritis "is a revisionist disease, which, if hand untreated, can significantly and non-stop reduce joint function, patient mobility and quality of life," swotting lead author Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR story release. "Studies have shown that patients reinforce peak benefit from rheumatoid arthritis treatment in the first two years - yet our evidence highlight significant discontinuation rates during this point period".
About half of rheumatoid arthritis patients stopped taking their medications within two years after they started them, a unknown examination finds June 2013. Rheumatoid arthritis affects about one in 100 citizenry worldwide and can cause advancing collaborative destruction, deformity, woe and stiffness. The disease can reduce corporeal function, quality of life and life expectancy. The pipe reason about one-third of patients discontinued their medications was because the drugs astray their effectiveness, the study authors found glucophage treatment. Other reasons included shelter concerns (20 percent), doctor favourite (nearly 28 percent), patient preference (about 18 percent) and access to therapy (9 percent), according to the sanctum results, which were presented Thursday at the annual meeting of the European League Against Rheumatism (EULAR), in Madrid, Spain.
Rheumatoid arthritis "is a revisionist disease, which, if hand untreated, can significantly and non-stop reduce joint function, patient mobility and quality of life," swotting lead author Dr Vibeke Strand, a clinical professor at Stanford University School of Medicine, said in an EULAR story release. "Studies have shown that patients reinforce peak benefit from rheumatoid arthritis treatment in the first two years - yet our evidence highlight significant discontinuation rates during this point period".
Tuesday, October 4, 2016
New Treatments For Patients With Colorectal And Liver Cancer
New Treatments For Patients With Colorectal And Liver Cancer.
For advanced colon cancer patients who have developed liver tumors, designated "radioactive beads" implanted near these tumors may elongate survival nearly a year longer than all patients on chemotherapy alone, a skimpy redesigned scan finds. The same study, however, found that a drug commonly captivated in the months before the procedure does not increase this survival benefit ayurvedic. The research, from Beaumont Hospitals in Michigan, helps go on the pact of how various treatment combinations for colorectal cancer - the third most ordinary cancer in American men and women - move how well each individual treatment works.
And "I definitely think there's a lot of margin for studying the associations between different types of treatments," said contemplation author Dr Dmitry Goldin, a radiology dweller at Beaumont. "There are constantly new treatments, but they come out so extravagant that we don't always know the consequences or complications of the associations. We want to study the sequence, or order, of treatments".
The study is scheduled to be presented Saturday at the International Symposium on Endovascular Therapy in Miami Beach, Fla. Research presented at orderly conferences has not been peer-reviewed or published and should be considered preliminary. Goldin and his colleagues reviewed medical records from 39 patients with advanced colon cancer who underwent a action known as yttrium-90 microsphere radioembolization.
This nonsurgical treatment, approved by the US Food and Drug Administration, implants insignificant radioactive beads near inoperable liver tumors. Thirty of the patients were pretreated with the stupefy Avastin (bevacizumab) in periods ranging from less than three months to more than nine months before the radioactive beads were placed.
For advanced colon cancer patients who have developed liver tumors, designated "radioactive beads" implanted near these tumors may elongate survival nearly a year longer than all patients on chemotherapy alone, a skimpy redesigned scan finds. The same study, however, found that a drug commonly captivated in the months before the procedure does not increase this survival benefit ayurvedic. The research, from Beaumont Hospitals in Michigan, helps go on the pact of how various treatment combinations for colorectal cancer - the third most ordinary cancer in American men and women - move how well each individual treatment works.
And "I definitely think there's a lot of margin for studying the associations between different types of treatments," said contemplation author Dr Dmitry Goldin, a radiology dweller at Beaumont. "There are constantly new treatments, but they come out so extravagant that we don't always know the consequences or complications of the associations. We want to study the sequence, or order, of treatments".
The study is scheduled to be presented Saturday at the International Symposium on Endovascular Therapy in Miami Beach, Fla. Research presented at orderly conferences has not been peer-reviewed or published and should be considered preliminary. Goldin and his colleagues reviewed medical records from 39 patients with advanced colon cancer who underwent a action known as yttrium-90 microsphere radioembolization.
This nonsurgical treatment, approved by the US Food and Drug Administration, implants insignificant radioactive beads near inoperable liver tumors. Thirty of the patients were pretreated with the stupefy Avastin (bevacizumab) in periods ranging from less than three months to more than nine months before the radioactive beads were placed.
Wednesday, May 11, 2016
Children Who Were Breastfed In The Future Much Better In School
Children Who Were Breastfed In The Future Much Better In School.
Adding to reports that breast-feeding boosts cognition health, a changed chew over finds that infants breast-fed for six months or longer, especially boys, do considerably better in prime at grow old 10 compared to bottle-fed tots, according to a rejuvenated study. "Breast-feeding should be promoted for both boys and girls for its clear benefits," said study leader Wendy Oddy, a researcher at the Telethon Institute for Child Health Research in Perth, Australia penis enlargement in. For the study, published online Dec 20, 2010 in Pediatrics, she and her colleagues looked at the theoretical scores at duration 10 of more than a thousand children whose mothers had enrolled in an unfolding burn the midnight oil in western Australia.
After adjusting for such factors as gender, set income, tender factors and early stimulation at home, such as reading to children, they estimated the links between breast-feeding and informative outcomes. Babies who were mainly breast-fed for six months or longer had higher visionary scores on standardized tests than those breast-fed fewer than six months, she found. But the after-effect diversified by gender, and the improvements were only significant from a statistical feature of view for the boys.
The boys had better scores in math, reading, spelling and script if they were breast-fed six months or longer. Girls breast-fed for six months or longer had a trivial but statistically piddling benefit in reading scores. The apology for the gender differences is unclear, but Oddy speculates that the jealous role of breast milk on the brain and its later consequences for interaction development may have greater benefits for boys because they are more vulnerable during ticklish development periods.
Another possibility has to do with the positive effect of breastfeeding on the mother-child relationship. "A bunch of studies found that boys are more reliant than girls on caring attention and encouragement for the acquisition of cognitive and words skills. If breastfeeding facilitates mother-child interactions, then we would look for the positive effects of this bond to be greater in males compared with females, as we observed".
Adding to reports that breast-feeding boosts cognition health, a changed chew over finds that infants breast-fed for six months or longer, especially boys, do considerably better in prime at grow old 10 compared to bottle-fed tots, according to a rejuvenated study. "Breast-feeding should be promoted for both boys and girls for its clear benefits," said study leader Wendy Oddy, a researcher at the Telethon Institute for Child Health Research in Perth, Australia penis enlargement in. For the study, published online Dec 20, 2010 in Pediatrics, she and her colleagues looked at the theoretical scores at duration 10 of more than a thousand children whose mothers had enrolled in an unfolding burn the midnight oil in western Australia.
After adjusting for such factors as gender, set income, tender factors and early stimulation at home, such as reading to children, they estimated the links between breast-feeding and informative outcomes. Babies who were mainly breast-fed for six months or longer had higher visionary scores on standardized tests than those breast-fed fewer than six months, she found. But the after-effect diversified by gender, and the improvements were only significant from a statistical feature of view for the boys.
The boys had better scores in math, reading, spelling and script if they were breast-fed six months or longer. Girls breast-fed for six months or longer had a trivial but statistically piddling benefit in reading scores. The apology for the gender differences is unclear, but Oddy speculates that the jealous role of breast milk on the brain and its later consequences for interaction development may have greater benefits for boys because they are more vulnerable during ticklish development periods.
Another possibility has to do with the positive effect of breastfeeding on the mother-child relationship. "A bunch of studies found that boys are more reliant than girls on caring attention and encouragement for the acquisition of cognitive and words skills. If breastfeeding facilitates mother-child interactions, then we would look for the positive effects of this bond to be greater in males compared with females, as we observed".
Subscribe to:
Posts (Atom)